Rapamycin cardiac function evaluated in elderly adults aged 70-95 in observational substudy with cardiac MRI.
This was a substudy (Substudy E) of a translational trial examining rapamycin's effects in elderly persons aged 70-95. The substudy specifically evaluated rapamycin and cardiac function using cardiac MRI with late gadolinium enhancement (LGE). No results were reported in the abstract provided.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Oct 8, 2025 · Discovered: Sep 19, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Other
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- Cardiac function
- Effect size
- —
- Significance
- Not reported
- Journal
- The University of Texas Health Science Center at San Antonio
- Published
- Sep 23, 2026
Sources
Primary source
Source versions
Assessment history
9/24/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.